Jay Lichter
Chief Executive Officer, AKESIS PHARMACEUTICALS, INC.
Companies
- Janux Therapeutics, Inc.Board member Jun 10, 2021 to Jun 28, 20241
- Otonomy (United States)Board member Aug 12, 2014 to Jun 23, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Janux Therapeutics, Inc. JANX3,028,414 shares3$52.5M at $17.32Oct 24, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 13, 2024Sold 3,815 shares at $46.68 of Janux Therapeutics, Inc.3
- Sep 13, 2024Exercised options 391 shares at $39.80 of Janux Therapeutics, Inc.3
- Sep 13, 2024Exercised options 778 shares at $13.22 of Janux Therapeutics, Inc.3
- Sep 13, 2024Exercised options 778 shares at $10.73 of Janux Therapeutics, Inc.3
- Sep 13, 2024Exercised options 1,868 shares at $17.00 of Janux Therapeutics, Inc.3
- Jun 26, 2024Granted 2,500 shares of Janux Therapeutics, Inc.4
- Jun 3, 2024Sold 691,525 shares at $54.75 of Janux Therapeutics, Inc.5
- Jun 3, 2024Sold 131,196 shares at $54.75 of Janux Therapeutics, Inc.5
- Jun 3, 2024Sold 677,279 shares at $54.75 of Janux Therapeutics, Inc.5
- Nov 13, 2023Bought 849,854 shares at $5.87 of Janux Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 28, 2024
- 5SEC EDGARForm 4 filed Jun 5, 2024
- 6SEC EDGARForm 4 filed Nov 15, 2023